1 / 8

China Cancer Drugs Market – Forecast by Drugs, Cancer & Therapy

Cancer is one of the biggest burdens for so many public health departments across the world and China has even more cancer patients due to growing population at rapid pace. According to GLOBCAN, nearly 2.9 Million new cancer deaths happened in China in the year 2018. According to Renub Research Analysis, China Cancer Drug Market will surpass US$ 30.5 Billion by the year end of 2025.<br>Access full Research: <br>https://www.renub.com/china-cancer-drugs-market-p.php

rresearch
Download Presentation

China Cancer Drugs Market – Forecast by Drugs, Cancer & Therapy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. China Cancer Drugs Market China Cancer Drugs Market

  2. Report Description and Highlights Cancer is one of the biggest burdens for so many public health departments across the world and China has even more cancer patients due to growing population at rapid pace. According to GLOBCAN, nearly 2.9 Million new cancer deaths happened in China in the year 2018. If we talk about cancer incidence, this rate is much lower in China rather than United States and United Kingdom. But when we talk about mortality rate, China mortality rate is almost 30% to 40% higher than the United States and United Kingdom. Moreover, increasing diagnostic center, improving cancer treatment therapy and acceptance of targeted drug therapy will further boost the China cancer market in forecast period. However, expensive cancer drug and various side-effects will also hinder the market. According to Renub Research Analysis, China Cancer Drug Market will surpass US$ 30.5 Billion by the year end of 2025. China Cancer Drugs Market

  3. China Cancer Drugs Market China cancer drug market has grown rapidly in historical period and it is expected to grow significantly during the forecast period. There are various factors that will help the market to outperform; rising ageing population in China, changes of lifestyle and food habits, rising incidence rate of several type of cancer, rise in tobacco smoking population due to expansion of urbanization in China, improving healthcare infrastructure and facilities in China, increasing per capita disposable income, rising per capita healthcare expenditure, improving awareness regarding cancer risk, potential due to emerging economies etc. China Cancer Drugs Market

  4. China Cancer Drugs Market Renub Research report titled “China Cancer Drugs Market, by Drugs [Cytotoxic Drugs (Antimetabolities, Plant Alkaloids, Alkylating Agents), Targeted Drugs, Monoclonal Antibiotics, Hormonal Drugs, Traditional Chinese Medicine (TCM), & Others], Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy (Chemotherapy, Targeted Therapy, Hormonal Therapy & Others), Companies (Merck, Celgene, Eli Lilly, Roche & Sino BioPharma)” provides a complete analysis of China Anti-Cancer Drugs Market. Request a free sample copy of the report: https://www.renub.com/request- sample-page.php?gturl=china-cancer-drugs-market-p.php China Cancer Drugs Market

  5. China Cancer Drugs Market China Cancer Drug Market Insight by Drug Type In this report, China cancer drugs market is fragmented by drug type into six parts; Targeted Drugs, Cytotoxic Drugs, Monoclonal Antibiotics, Hormonal Drugs, TCM and Others. Cytotoxic Drugs type is further categorized into three parts; Antimetabolites, Plant Alkaloids and Alkylating Agents. Currently targeted drugs have more ability to kill malignant cells and it is quite popular because of higher success rate and efficacy. China Cancer Drug Market Insight by Types of Cancer In this report, we have done in-depth analysis of market by types of cancer; Lung, Stomach, Breast, Esophageal, Liver & Others China Cancer Drug Market Insight by Therapy According Renub Research, targeted drug therapy is growing significantly in China due its higher efficacy and success rate than other therapy. In this report, we have design multi-dimensional approach to study all the cancer therapy which includes various important variables such as prime factors that support market growth, opportunities in each therapy, challenges faced by particular therapy etc. China Cancer Drugs Market

  6. China Cancer Drugs Market By Cancer • Lung Cancer • Stomach Cancer • Breast Cancer • Esophageal Cancer • Liver Cancer • Others By Drugs • Cytotoxic Drugs o Antimetabolities o Plant Alkaloids o Alkylating Agents • Targeted Drugs • Monoclonal Antibiotics • Hormonal Drugs • Traditional Chinese Medicine (TCM) • Others China Cancer Drugs Market

  7. China Cancer Drugs Market By Therapy • Chemotherapy • Targeted Therapy • Hormonal Therapy • Others Companies Covered in the Report • Merck • Celegene • Eli Lilly • Roche • Sino BioPharma Request a free Brochure copy of the report: https://www.renub.com/request- brochure-page.php?gturl=china-cancer-drugs-market-p.php China Cancer Drugs Market

  8. China Cancer Drugs Market Browse Related Report : Epilepsy Drugs Market Diabetes Drug Market Contact Us Tel: +1-678-302-0700 (US), +91-120-421-9822 (INDIA) Email: info@renub.com China Cancer Drugs Market

More Related